Omental Macrophagic “Crown-like Structures” Are Associated with Poor Prognosis in Advanced-Stage Serous Ovarian Cancer
The tumor microenvironment is a well-recognized framework in which immune cells present in the tumor microenvironment promote or inhibit cancer formation and development. A crown-like structure (CLS) has been reported as a dying or dead adipocyte surrounded by a ‘crown’ of macrophages within adipose...
Saved in:
| Published in | Current oncology (Toronto) Vol. 28; no. 5; pp. 4234 - 4246 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
MDPI
19.10.2021
MDPI AG |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1718-7729 1198-0052 1718-7729 |
| DOI | 10.3390/curroncol28050359 |
Cover
| Abstract | The tumor microenvironment is a well-recognized framework in which immune cells present in the tumor microenvironment promote or inhibit cancer formation and development. A crown-like structure (CLS) has been reported as a dying or dead adipocyte surrounded by a ‘crown’ of macrophages within adipose tissue, which is a histologic hallmark of the inflammatory process in this tissue. CLSs have also been found to be related to formation, progression and prognosis of some types of cancer. However, the presence of CLSs in the omentum of advanced-stage high-grade serous ovarian carcinoma (HGSOC) has not been thoroughly investigated. By using CD68, a pan-macrophage marker, and CD163, an M2-like polarization macrophage marker, immunohistochemistry (IHC) was performed to identify tumor-associated macrophages (TAMs) and CLSs. This retrospective study analyzed 116 patients with advanced-stage HGSOC who received complete treatment and had available clinical data from July 2008 through December 2016 at National Cheng Kung University Hospital (NCKUH) (Tainan, Taiwan). Based on multivariate Cox regression analysis, patients with omental CD68+ CLSs had poor OS (median survival: 24 vs. 38 months, p = 0.001, hazard ratio (HR): 2.26, 95% confidence interval (CI): 1.41–3.61); patients with omental CD163+ CLSs also had poor OS (median survival: 22 vs. 36 months, HR: 2.14, 95%CI: 1.33–3.44, p = 0.002). Additionally, patients with omental CD68+ or CD163+ CLSs showed poor PFS (median survival: 11 vs. 15 months, HR: 2.28, 95%CI: 1.43–3.64, p = 0.001; median survival: 11 vs. 15 months, HR: 2.17, 95%CI: 1.35–3.47, respectively, p = 0.001). Conversely, the density of CD68+ or CD163+ TAMs in ovarian tumors was not associated with patient prognosis in advanced-stage HGSOC in our cohort. In conclusion, we, for the first time, demonstrate that the presence of omental CLSs is associated with poor prognosis in advanced-stage HGSOC. |
|---|---|
| AbstractList | The tumor microenvironment is a well-recognized framework in which immune cells present in the tumor microenvironment promote or inhibit cancer formation and development. A crown-like structure (CLS) has been reported as a dying or dead adipocyte surrounded by a ‘crown’ of macrophages within adipose tissue, which is a histologic hallmark of the inflammatory process in this tissue. CLSs have also been found to be related to formation, progression and prognosis of some types of cancer. However, the presence of CLSs in the omentum of advanced-stage high-grade serous ovarian carcinoma (HGSOC) has not been thoroughly investigated. By using CD68, a pan-macrophage marker, and CD163, an M2-like polarization macrophage marker, immunohistochemistry (IHC) was performed to identify tumor-associated macrophages (TAMs) and CLSs. This retrospective study analyzed 116 patients with advanced-stage HGSOC who received complete treatment and had available clinical data from July 2008 through December 2016 at National Cheng Kung University Hospital (NCKUH) (Tainan, Taiwan). Based on multivariate Cox regression analysis, patients with omental CD68+ CLSs had poor OS (median survival: 24 vs. 38 months, p = 0.001, hazard ratio (HR): 2.26, 95% confidence interval (CI): 1.41–3.61); patients with omental CD163+ CLSs also had poor OS (median survival: 22 vs. 36 months, HR: 2.14, 95%CI: 1.33–3.44, p = 0.002). Additionally, patients with omental CD68+ or CD163+ CLSs showed poor PFS (median survival: 11 vs. 15 months, HR: 2.28, 95%CI: 1.43–3.64, p = 0.001; median survival: 11 vs. 15 months, HR: 2.17, 95%CI: 1.35–3.47, respectively, p = 0.001). Conversely, the density of CD68+ or CD163+ TAMs in ovarian tumors was not associated with patient prognosis in advanced-stage HGSOC in our cohort. In conclusion, we, for the first time, demonstrate that the presence of omental CLSs is associated with poor prognosis in advanced-stage HGSOC. The tumor microenvironment is a well-recognized framework in which immune cells present in the tumor microenvironment promote or inhibit cancer formation and development. A crown-like structure (CLS) has been reported as a dying or dead adipocyte surrounded by a 'crown' of macrophages within adipose tissue, which is a histologic hallmark of the inflammatory process in this tissue. CLSs have also been found to be related to formation, progression and prognosis of some types of cancer. However, the presence of CLSs in the omentum of advanced-stage high-grade serous ovarian carcinoma (HGSOC) has not been thoroughly investigated. By using CD68, a pan-macrophage marker, and CD163, an M2-like polarization macrophage marker, immunohistochemistry (IHC) was performed to identify tumor-associated macrophages (TAMs) and CLSs. This retrospective study analyzed 116 patients with advanced-stage HGSOC who received complete treatment and had available clinical data from July 2008 through December 2016 at National Cheng Kung University Hospital (NCKUH) (Tainan, Taiwan). Based on multivariate Cox regression analysis, patients with omental CD68+ CLSs had poor OS (median survival: 24 vs. 38 months, p = 0.001, hazard ratio (HR): 2.26, 95% confidence interval (CI): 1.41-3.61); patients with omental CD163+ CLSs also had poor OS (median survival: 22 vs. 36 months, HR: 2.14, 95%CI: 1.33-3.44, p = 0.002). Additionally, patients with omental CD68+ or CD163+ CLSs showed poor PFS (median survival: 11 vs. 15 months, HR: 2.28, 95%CI: 1.43-3.64, p = 0.001; median survival: 11 vs. 15 months, HR: 2.17, 95%CI: 1.35-3.47, respectively, p = 0.001). Conversely, the density of CD68+ or CD163+ TAMs in ovarian tumors was not associated with patient prognosis in advanced-stage HGSOC in our cohort. In conclusion, we, for the first time, demonstrate that the presence of omental CLSs is associated with poor prognosis in advanced-stage HGSOC.The tumor microenvironment is a well-recognized framework in which immune cells present in the tumor microenvironment promote or inhibit cancer formation and development. A crown-like structure (CLS) has been reported as a dying or dead adipocyte surrounded by a 'crown' of macrophages within adipose tissue, which is a histologic hallmark of the inflammatory process in this tissue. CLSs have also been found to be related to formation, progression and prognosis of some types of cancer. However, the presence of CLSs in the omentum of advanced-stage high-grade serous ovarian carcinoma (HGSOC) has not been thoroughly investigated. By using CD68, a pan-macrophage marker, and CD163, an M2-like polarization macrophage marker, immunohistochemistry (IHC) was performed to identify tumor-associated macrophages (TAMs) and CLSs. This retrospective study analyzed 116 patients with advanced-stage HGSOC who received complete treatment and had available clinical data from July 2008 through December 2016 at National Cheng Kung University Hospital (NCKUH) (Tainan, Taiwan). Based on multivariate Cox regression analysis, patients with omental CD68+ CLSs had poor OS (median survival: 24 vs. 38 months, p = 0.001, hazard ratio (HR): 2.26, 95% confidence interval (CI): 1.41-3.61); patients with omental CD163+ CLSs also had poor OS (median survival: 22 vs. 36 months, HR: 2.14, 95%CI: 1.33-3.44, p = 0.002). Additionally, patients with omental CD68+ or CD163+ CLSs showed poor PFS (median survival: 11 vs. 15 months, HR: 2.28, 95%CI: 1.43-3.64, p = 0.001; median survival: 11 vs. 15 months, HR: 2.17, 95%CI: 1.35-3.47, respectively, p = 0.001). Conversely, the density of CD68+ or CD163+ TAMs in ovarian tumors was not associated with patient prognosis in advanced-stage HGSOC in our cohort. In conclusion, we, for the first time, demonstrate that the presence of omental CLSs is associated with poor prognosis in advanced-stage HGSOC. The tumor microenvironment is a well-recognized framework in which immune cells present in the tumor microenvironment promote or inhibit cancer formation and development. A crown-like structure (CLS) has been reported as a dying or dead adipocyte surrounded by a ‘crown’ of macrophages within adipose tissue, which is a histologic hallmark of the inflammatory process in this tissue. CLSs have also been found to be related to formation, progression and prognosis of some types of cancer. However, the presence of CLSs in the omentum of advanced-stage high-grade serous ovarian carcinoma (HGSOC) has not been thoroughly investigated. By using CD68, a pan-macrophage marker, and CD163, an M2-like polarization macrophage marker, immunohistochemistry (IHC) was performed to identify tumor-associated macrophages (TAMs) and CLSs. This retrospective study analyzed 116 patients with advanced-stage HGSOC who received complete treatment and had available clinical data from July 2008 through December 2016 at National Cheng Kung University Hospital (NCKUH) (Tainan, Taiwan). Based on multivariate Cox regression analysis, patients with omental CD68 + CLSs had poor OS (median survival: 24 vs. 38 months, p = 0.001, hazard ratio (HR): 2.26, 95% confidence interval (CI): 1.41–3.61); patients with omental CD163 + CLSs also had poor OS (median survival: 22 vs. 36 months, HR: 2.14, 95%CI: 1.33–3.44, p = 0.002). Additionally, patients with omental CD68 + or CD163 + CLSs showed poor PFS (median survival: 11 vs. 15 months, HR: 2.28, 95%CI: 1.43–3.64, p = 0.001; median survival: 11 vs. 15 months, HR: 2.17, 95%CI: 1.35–3.47, respectively, p = 0.001). Conversely, the density of CD68 + or CD163 + TAMs in ovarian tumors was not associated with patient prognosis in advanced-stage HGSOC in our cohort. In conclusion, we, for the first time, demonstrate that the presence of omental CLSs is associated with poor prognosis in advanced-stage HGSOC. |
| Author | Wu, Pei-Ying Tsai, Hsing-Fen Lin, Chang-Ni Liang, Yu-Ling Lin, Sheng-Hsiang Hsu, Keng-Fu Hong, Tse-Ming |
| AuthorAffiliation | 1 Department of Obstetrics and Gynecology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan; n625526@mail.hosp.ncku.edu.tw (Y.-L.L.); cnlin031@gmail.com (C.-N.L.); tsaihf@mail.ncku.edu.tw (H.-F.T.); anna1002ster@gmail.com (P.-Y.W.) 2 Graduate Institute of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan; shlin922@mail.ncku.edu.tw |
| AuthorAffiliation_xml | – name: 2 Graduate Institute of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan; shlin922@mail.ncku.edu.tw – name: 1 Department of Obstetrics and Gynecology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan; n625526@mail.hosp.ncku.edu.tw (Y.-L.L.); cnlin031@gmail.com (C.-N.L.); tsaihf@mail.ncku.edu.tw (H.-F.T.); anna1002ster@gmail.com (P.-Y.W.) |
| Author_xml | – sequence: 1 givenname: Yu-Ling surname: Liang fullname: Liang, Yu-Ling – sequence: 2 givenname: Chang-Ni surname: Lin fullname: Lin, Chang-Ni – sequence: 3 givenname: Hsing-Fen surname: Tsai fullname: Tsai, Hsing-Fen – sequence: 4 givenname: Pei-Ying orcidid: 0000-0002-8168-6125 surname: Wu fullname: Wu, Pei-Ying – sequence: 5 givenname: Sheng-Hsiang surname: Lin fullname: Lin, Sheng-Hsiang – sequence: 6 givenname: Tse-Ming surname: Hong fullname: Hong, Tse-Ming – sequence: 7 givenname: Keng-Fu orcidid: 0000-0002-2698-4971 surname: Hsu fullname: Hsu, Keng-Fu |
| BookMark | eNp9kctuEzEUhkeoiF7gAdh5yWbA17G9QYoiLpWKUqmwthzPycRlYgfbkwpWfRB4uT4JDqkQBYmVrXP-_ztH5z9tjkIM0DTPCX7JmMav3JRSDC6OVGGBmdCPmhMiiWqlpProj_9xc5rzNcaMSSmfNMeMd7Us5UnzbbGBUOyIPliX4nZtB-_Q3e33eYo3oR39Z0BXJU2uTAny3e0PNEuAZjlH522BHt34skaXMSZ0meIQYvYZ-YBm_c4GB317VexQEZDilNFiZ5O3Ac33vfS0ebyyY4Zn9-9Z8-ntm4_z9-3F4t35fHbROs5paQEY5RSDXva9dgrALa3DnHDQPQegGpRjisoelAQhnSJYVIGjnRAcg2VnzfmB20d7bbbJb2z6aqL15lchpsHYVLwbwXQgBdW8W3Fbhy-ZFoRoQUWnBFnRnlXW6wNrOy030Lt6u2THB9CHneDXZog7owTjiqoKeHEPSPHLBLmYjc8OxtEGqCcyVCjOOSZYVyk5SGswOSdY_R5DsNnnb_7Jv3rkXx7niy0-7rfx43-cPwGqZb12 |
| CitedBy_id | crossref_primary_10_1016_j_intimp_2024_112911 crossref_primary_10_3389_fendo_2022_886533 crossref_primary_10_1186_s12929_024_01051_4 crossref_primary_10_3390_ijms25158352 crossref_primary_10_1111_apt_17995 crossref_primary_10_1186_s12964_023_01384_x crossref_primary_10_1136_jitc_2022_005968 crossref_primary_10_3390_nu16172822 crossref_primary_10_1177_15598276221123764 |
| Cites_doi | 10.1158/1078-0432.CCR-06-2073 10.1002/ijc.28335 10.1158/0008-5472.CAN-19-2994 10.1002/cncr.30251 10.1038/nrclinonc.2016.217 10.1097/IGC.0b013e3182070f17 10.1016/j.ebiom.2019.102602 10.1038/nrd.2018.169 10.1371/journal.pone.0154003 10.1038/bjc.2015.254 10.1016/j.ygyno.2017.07.007 10.1016/j.cell.2016.01.043 10.1038/pcan.2017.31 10.1186/s13058-020-01308-4 10.1158/1078-0432.CCR-15-2239 10.1038/s41574-018-0126-x 10.1038/nm.2492 10.1016/j.cyto.2012.01.015 10.1038/s41598-019-49649-1 10.1158/1940-6207.CAPR-17-0245 10.1158/1940-6207.CAPR-16-0314 10.2353/ajpath.2010.100105 10.1194/jlr.M800019-JLR200 10.1016/j.ygyno.2014.08.028 10.1016/j.humpath.2017.12.010 10.1007/s10549-018-4722-1 10.1016/j.it.2017.03.002 10.1136/jitc-2020-000638 10.1080/2162402X.2017.1342918 10.3389/fimmu.2017.01129 10.1186/1757-2215-7-19 10.1016/j.smim.2020.101408 10.1016/j.ejca.2008.10.026 10.7150/jca.34886 10.4049/jimmunol.204.Supp.240.9 10.1371/journal.pone.0050946 10.1016/j.plipres.2017.11.002 10.1016/j.ccell.2015.02.015 10.1038/s41467-020-18742-9 10.1161/CIRCRESAHA.119.315833 10.1172/jci.insight.92902 10.1371/journal.pone.0170042 10.1038/nature01322 10.4048/jbc.2020.23.e35 10.3390/cells9020305 10.1016/j.bbalip.2013.02.010 10.1158/2159-8290.CD-17-0284 10.1172/JCI200319246 10.1186/s12885-015-1114-3 10.1007/s10549-016-3847-3 10.1016/j.ygyno.2008.01.010 10.1002/jso.21288 10.1126/science.aaw2586 10.1016/S1470-2045(06)70939-1 |
| ContentType | Journal Article |
| Copyright | 2021 by the authors. 2021 |
| Copyright_xml | – notice: 2021 by the authors. 2021 |
| DBID | AAYXX CITATION 7X8 5PM DOA |
| DOI | 10.3390/curroncol28050359 |
| DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1718-7729 |
| EndPage | 4246 |
| ExternalDocumentID | oai_doaj_org_article_6e752946f4ac44b3951195256851f2d3 PMC8534828 10_3390_curroncol28050359 |
| GroupedDBID | --- 04C 29F 2WC 53G 5GY 5VS 6PF AAWTL AAYXX ABDBF ACGFS ACUHS ADBBV AENEX AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BMSDO CITATION CS3 DIK DU5 E3Z EBD EBS EIHBH EJD ESX F5P GROUPED_DOAJ HYE KQ8 MODMG OK1 OVT RNS RPM TR2 TUS 7X8 5PM |
| ID | FETCH-LOGICAL-c442t-ee32420e9bdd9c8eecbac0414e9d4ee29e8c3827de87e57c8105ac0c265540ea3 |
| IEDL.DBID | DOA |
| ISSN | 1718-7729 1198-0052 |
| IngestDate | Wed Aug 27 01:24:09 EDT 2025 Thu Aug 21 18:01:30 EDT 2025 Thu Jul 10 23:18:43 EDT 2025 Tue Jul 01 02:54:38 EDT 2025 Thu Apr 24 22:59:34 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c442t-ee32420e9bdd9c8eecbac0414e9d4ee29e8c3827de87e57c8105ac0c265540ea3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work. |
| ORCID | 0000-0002-8168-6125 0000-0002-2698-4971 |
| OpenAccessLink | https://doaj.org/article/6e752946f4ac44b3951195256851f2d3 |
| PMID | 34677277 |
| PQID | 2584440109 |
| PQPubID | 23479 |
| PageCount | 13 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_6e752946f4ac44b3951195256851f2d3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8534828 proquest_miscellaneous_2584440109 crossref_primary_10_3390_curroncol28050359 crossref_citationtrail_10_3390_curroncol28050359 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20211019 |
| PublicationDateYYYYMMDD | 2021-10-19 |
| PublicationDate_xml | – month: 10 year: 2021 text: 20211019 day: 19 |
| PublicationDecade | 2020 |
| PublicationTitle | Current oncology (Toronto) |
| PublicationYear | 2021 |
| Publisher | MDPI MDPI AG |
| Publisher_xml | – name: MDPI – name: MDPI AG |
| References | Pearce (ref_18) 2018; 8 Yuan (ref_11) 2017; 147 Jing (ref_40) 2020; 11 ref_14 Maliniak (ref_41) 2020; 22 Su (ref_48) 2020; 80 Eisenhauer (ref_34) 2009; 45 ref_51 Quail (ref_37) 2019; 15 Liang (ref_39) 2019; 10 Rabold (ref_49) 2020; 8 Malesci (ref_7) 2017; 6 Chen (ref_46) 2019; 125 Iyengar (ref_55) 2017; 10 Santander (ref_28) 2016; 158 Flaherty (ref_45) 2019; 363 Cassetta (ref_2) 2018; 17 Xu (ref_47) 2020; 204 Rustin (ref_35) 2012; 21 Randall (ref_17) 2017; 38 Gucalp (ref_32) 2017; 20 ref_25 Madeddu (ref_44) 2012; 58 Tan (ref_54) 2006; 7 Ruffell (ref_4) 2015; 27 Iyengar (ref_31) 2016; 122 Reinartz (ref_42) 2014; 134 Yang (ref_43) 2019; 9 Lengyel (ref_15) 2010; 177 Ojalvo (ref_13) 2018; 74 Nieman (ref_20) 2013; 1831 Murano (ref_24) 2008; 49 Coussens (ref_26) 2002; 420 Zhang (ref_10) 2014; 7 Farinasso (ref_22) 2017; 8 Liu (ref_52) 2020; 51 Shah (ref_12) 2008; 109 Sehouli (ref_16) 2009; 99 Itoh (ref_33) 2017; 2 Faria (ref_30) 2020; 23 Weisberg (ref_23) 2003; 112 Tkach (ref_50) 2016; 164 Mantovani (ref_1) 2017; 14 Hsu (ref_36) 2015; 113 Forssell (ref_6) 2007; 13 Choi (ref_21) 2018; 69 ref_3 Cha (ref_38) 2018; 170 ref_9 Ayub (ref_5) 2014; 135 ref_8 Nieman (ref_19) 2011; 17 Iyengar (ref_27) 2016; 22 Cortese (ref_53) 2020; 48 Carter (ref_29) 2018; 11 |
| References_xml | – volume: 13 start-page: 1472 year: 2007 ident: ref_6 article-title: High macrophage infiltration along the tumor front correlates with improved survival in colon cancer publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-06-2073 – volume: 134 start-page: 32 year: 2014 ident: ref_42 article-title: Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse publication-title: Int. J. Cancer doi: 10.1002/ijc.28335 – volume: 80 start-page: 1438 year: 2020 ident: ref_48 article-title: Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-19-2994 – volume: 122 start-page: 3794 year: 2016 ident: ref_31 article-title: White adipose tissue inflammation and cancer-specific survival in patients with squamous cell carcinoma of the oral tongue publication-title: Cancer doi: 10.1002/cncr.30251 – volume: 14 start-page: 399 year: 2017 ident: ref_1 article-title: Tumour-associated macrophages as treatment targets in oncology publication-title: Nat. Rev. Clin. Oncol doi: 10.1038/nrclinonc.2016.217 – volume: 21 start-page: 419 year: 2012 ident: ref_35 article-title: Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG) publication-title: Int. J. Gynecol. Cancer doi: 10.1097/IGC.0b013e3182070f17 – volume: 51 start-page: 102602 year: 2020 ident: ref_52 article-title: Tumor immune cell infiltration and survival after platinum-based chemotherapy in high-grade serous ovarian cancer subtypes: A gene expression-based computational study publication-title: EBioMedicine doi: 10.1016/j.ebiom.2019.102602 – volume: 17 start-page: 887 year: 2018 ident: ref_2 article-title: Targeting macrophages: Therapeutic approaches in cancer publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd.2018.169 – ident: ref_25 doi: 10.1371/journal.pone.0154003 – volume: 113 start-page: 414 year: 2015 ident: ref_36 article-title: Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer publication-title: Br. J. Cancer doi: 10.1038/bjc.2015.254 – volume: 147 start-page: 181 year: 2017 ident: ref_11 article-title: Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2017.07.007 – volume: 164 start-page: 1226 year: 2016 ident: ref_50 article-title: Communication by Extracellular Vesicles: Where We Are and Where We Need to Go publication-title: Cell doi: 10.1016/j.cell.2016.01.043 – volume: 20 start-page: 418 year: 2017 ident: ref_32 article-title: Periprostatic adipose inflammation is associated with high-grade prostate cancer publication-title: Prostate Cancer Prostatic. Dis. doi: 10.1038/pcan.2017.31 – volume: 22 start-page: 65 year: 2020 ident: ref_41 article-title: Detection of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White women with breast cancer publication-title: Breast Cancer Res. doi: 10.1186/s13058-020-01308-4 – volume: 22 start-page: 2283 year: 2016 ident: ref_27 article-title: Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-15-2239 – volume: 15 start-page: 139 year: 2019 ident: ref_37 article-title: The obese adipose tissue microenvironment in cancer development and progression publication-title: Nat. Rev. Endocrinol. doi: 10.1038/s41574-018-0126-x – volume: 17 start-page: 1498 year: 2011 ident: ref_19 article-title: Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth publication-title: Nat. Med. doi: 10.1038/nm.2492 – volume: 58 start-page: 133 year: 2012 ident: ref_44 article-title: Inflammation and ovarian cancer publication-title: Cytokine doi: 10.1016/j.cyto.2012.01.015 – volume: 9 start-page: 13316 year: 2019 ident: ref_43 article-title: Adipocytes promote ovarian cancer chemoresistance publication-title: Sci. Rep. doi: 10.1038/s41598-019-49649-1 – volume: 11 start-page: 113 year: 2018 ident: ref_29 article-title: Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease publication-title: Cancer Prev. Res. doi: 10.1158/1940-6207.CAPR-17-0245 – volume: 10 start-page: 235 year: 2017 ident: ref_55 article-title: Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass Index publication-title: Cancer Prev. Res. doi: 10.1158/1940-6207.CAPR-16-0314 – volume: 177 start-page: 1053 year: 2010 ident: ref_15 article-title: Ovarian cancer development and metastasis publication-title: Am. J. Pathol. doi: 10.2353/ajpath.2010.100105 – volume: 49 start-page: 1562 year: 2008 ident: ref_24 article-title: Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice publication-title: J. Lipid. Res. doi: 10.1194/jlr.M800019-JLR200 – volume: 135 start-page: 176 year: 2014 ident: ref_5 article-title: Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2014.08.028 – volume: 74 start-page: 135 year: 2018 ident: ref_13 article-title: Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer publication-title: Hum. Pathol. doi: 10.1016/j.humpath.2017.12.010 – volume: 170 start-page: 15 year: 2018 ident: ref_38 article-title: Tumor-associated macrophages and crown-like structures in adipose tissue in breast cancer publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-018-4722-1 – volume: 38 start-page: 526 year: 2017 ident: ref_17 article-title: Immunological Functions of the Omentum publication-title: Trends. Immunol. doi: 10.1016/j.it.2017.03.002 – ident: ref_14 – volume: 8 start-page: e000638 year: 2020 ident: ref_49 article-title: Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristics publication-title: J. Immunother. Cancer doi: 10.1136/jitc-2020-000638 – volume: 6 start-page: e1342918 year: 2017 ident: ref_7 article-title: Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer publication-title: Oncoimmunology doi: 10.1080/2162402X.2017.1342918 – volume: 8 start-page: 1129 year: 2017 ident: ref_22 article-title: Adipocytes and Macrophages Interplay in the Orchestration of Tumor Microenvironment: New Implications in Cancer Progression publication-title: Front. Immunol. doi: 10.3389/fimmu.2017.01129 – volume: 7 start-page: 19 year: 2014 ident: ref_10 article-title: A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients publication-title: J. Ovarian Res. doi: 10.1186/1757-2215-7-19 – volume: 48 start-page: 101408 year: 2020 ident: ref_53 article-title: Prognostic significance of tumor-associated macrophages: Past, present and future publication-title: Semin. Immunol. doi: 10.1016/j.smim.2020.101408 – volume: 45 start-page: 228 year: 2009 ident: ref_34 article-title: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) publication-title: Eur. J. Cancer doi: 10.1016/j.ejca.2008.10.026 – volume: 10 start-page: 6025 year: 2019 ident: ref_39 article-title: Downregulated Salt-inducible Kinase 3 Expression Promotes Chemoresistance in Serous Ovarian Cancer via the ATP-binding Cassette Protein ABCG2 publication-title: J. Cancer doi: 10.7150/jca.34886 – volume: 204 start-page: 240.9 year: 2020 ident: ref_47 article-title: The role of CD36 in macrophage lipid metabolism and function in tumor microenvironment publication-title: J. Immunol. doi: 10.4049/jimmunol.204.Supp.240.9 – ident: ref_3 doi: 10.1371/journal.pone.0050946 – volume: 69 start-page: 11 year: 2018 ident: ref_21 article-title: Adipocyte biology in breast cancer: From silent bystander to active facilitator publication-title: Prog. Lipid. Res. doi: 10.1016/j.plipres.2017.11.002 – volume: 27 start-page: 462 year: 2015 ident: ref_4 article-title: Macrophages and therapeutic resistance in cancer publication-title: Cancer Cell doi: 10.1016/j.ccell.2015.02.015 – volume: 11 start-page: 4946 year: 2020 ident: ref_40 article-title: Multiomics prediction of immune-related adverse events during checkpoint immunotherapy publication-title: Nat. Commun. doi: 10.1038/s41467-020-18742-9 – volume: 125 start-page: 1087 year: 2019 ident: ref_46 article-title: Mitochondrial Metabolic Reprogramming by CD36 Signaling Drives Macrophage Inflammatory Responses publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.119.315833 – volume: 2 start-page: e92902 year: 2017 ident: ref_33 article-title: CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis publication-title: JCI Insight doi: 10.1172/jci.insight.92902 – ident: ref_8 doi: 10.1371/journal.pone.0170042 – volume: 420 start-page: 860 year: 2002 ident: ref_26 article-title: Inflammation and cancer publication-title: Nature doi: 10.1038/nature01322 – volume: 23 start-page: 233 year: 2020 ident: ref_30 article-title: Obesity and Breast Cancer: The Role of Crown-Like Structures in Breast Adipose Tissue in Tumor Progression, Prognosis, and Therapy publication-title: J. Breast Cancer doi: 10.4048/jbc.2020.23.e35 – ident: ref_51 doi: 10.3390/cells9020305 – volume: 1831 start-page: 1533 year: 2013 ident: ref_20 article-title: Adipose tissue and adipocytes support tumorigenesis and metastasis publication-title: Biochim. Biophys. Acta. doi: 10.1016/j.bbalip.2013.02.010 – volume: 8 start-page: 304 year: 2018 ident: ref_18 article-title: Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-17-0284 – volume: 112 start-page: 1796 year: 2003 ident: ref_23 article-title: Obesity is associated with macrophage accumulation in adipose tissue publication-title: J. Clin. Invest. doi: 10.1172/JCI200319246 – ident: ref_9 doi: 10.1186/s12885-015-1114-3 – volume: 158 start-page: 113 year: 2016 ident: ref_28 article-title: Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-016-3847-3 – volume: 109 start-page: 215 year: 2008 ident: ref_12 article-title: Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: Association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2008.01.010 – volume: 99 start-page: 424 year: 2009 ident: ref_16 article-title: Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer publication-title: J. Surg. Oncol. doi: 10.1002/jso.21288 – volume: 363 start-page: 989 year: 2019 ident: ref_45 article-title: A lipase-independent pathway of lipid release and immune modulation by adipocytes publication-title: Science doi: 10.1126/science.aaw2586 – volume: 7 start-page: 925 year: 2006 ident: ref_54 article-title: Mechanisms of transcoelomic metastasis in ovarian cancer publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(06)70939-1 |
| SSID | ssj0033777 |
| Score | 2.3108642 |
| Snippet | The tumor microenvironment is a well-recognized framework in which immune cells present in the tumor microenvironment promote or inhibit cancer formation and... |
| SourceID | doaj pubmedcentral proquest crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
| StartPage | 4234 |
| SubjectTerms | advanced-stage high-grade serous ovarian carcinoma (HGSOC) crown-like structure (CLS) omentum tumor microenvironment |
| Title | Omental Macrophagic “Crown-like Structures” Are Associated with Poor Prognosis in Advanced-Stage Serous Ovarian Cancer |
| URI | https://www.proquest.com/docview/2584440109 https://pubmed.ncbi.nlm.nih.gov/PMC8534828 https://doaj.org/article/6e752946f4ac44b3951195256851f2d3 |
| Volume | 28 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA7iQbyIT1xfRPAkBLtpmiZHXRQRVgUVvJU2mdVFaaXrevDkD9E_5y9xpu3KFkEvXpv0wcw0-b7O9BvG9pTRJsLgEdpnsVBeZwJnejHwpP7V7ToJ9KNw_1yf3qiz2-h2qtUX1YTV8sC14Q40xJG0Sg9U6pTKQkuJrwg3aoQKA-krnc_ABhMyVa_BYRjHdVsV-oEsiGSdzwyR4B-4cVkWOVpZGtJCIZHSqR2pEu5voc12reTU5nOyyBYa1MgP66ddYjOQL7O5fpMXX2GvF7VGP--n1JLrPsX1jH--vfeIZIvH4QPwq0oodozs-vPtA68EfOIZ8Jy-xvLLoij5ZVlQ6d1wxIc5P2wKBARC0ju8BJTFeMQvXpBfpznv0Vi5ym5Ojq97p6LpqiDQfvJZABCGCsBm3ltnAFyWukB1FVivAKQF40IjYw8mhih2BhEYTnBSI_IIIA3X2Gxe5LDOeAgZ8g010IC0zDlpIme7SnpEJSBBqw4LJpZNXCM5Tp0vHhOkHuSM5IczOmz_-5SnWm_jt8lH5K7viSSVXR3AAEqaAEr-CqAO2504O8FXi_IlaQ5ozkQiOFOKcocdFreioHXH9kg-vK9EuhEGKWSzG__xiJtsXlIpDRXS2C02iwED24iFnrOdKuy_AFrKCqE |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Omental+Macrophagic+%E2%80%9CCrown-like+Structures%E2%80%9D+Are+Associated+with+Poor+Prognosis+in+Advanced-Stage+Serous+Ovarian+Cancer&rft.jtitle=Current+oncology+%28Toronto%29&rft.au=Liang%2C+Yu-Ling&rft.au=Lin%2C+Chang-Ni&rft.au=Tsai%2C+Hsing-Fen&rft.au=Wu%2C+Pei-Ying&rft.date=2021-10-19&rft.pub=MDPI&rft.issn=1198-0052&rft.eissn=1718-7729&rft.volume=28&rft.issue=5&rft.spage=4234&rft.epage=4246&rft_id=info:doi/10.3390%2Fcurroncol28050359&rft_id=info%3Apmid%2F34677277&rft.externalDocID=PMC8534828 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1718-7729&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1718-7729&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1718-7729&client=summon |